Clinakos is live at booth #54 at Reuters Pharma USA 2025

Clinakos, Rare Disease, Integrated Patient Data, Medically Smart AI, Pharma USA

WE ARE LIVE NOW! We’ve landed at Booth #54 at Reuters Events Pharma USA 2025 in Philadelphia! Join us to meet our team and experience the future of life sciences with Clinakos Inc. Discover how we’re redefining healthcare through innovation. We’re excited to showcase how Clinakos Inc. is transforming the industry with Integrated Patient Data™ […]

Multiple Myeloma Awareness Month

Clinakos, Integrated Patient Data, Medically Smart AI, Rare diseases, Multiplt Myeloma

As we mark Multiple Myeloma Awareness Month, we’re excited to highlight the groundbreaking advancements in therapies transforming patient care in the U.S. Recent breakthroughs include monoclonal antibodies, which have significantly improved outcomes when combined with standard therapies. CAR T-cell therapies offer personalized treatment options for relapsed or refractory cases, providing hope for patients who have […]

Clinakos will be exhibiting at Reuters Pharma USA 2025

Clinakos, Rare Disease, Integrated Patient Data, Medically Smart AI, Pharma USA

We are thrilled to announce that Clinakos Inc. will be exhibiting at Reuters Events Pharma USA 2025! This is a unique opportunity to learn about how Clinakos is transforming the life sciences sector with its pioneering Integrated Patient Data™ and Medically Smart AI™. Our cutting-edge solutions are revolutionizing how life science companies engage with niche […]

Meet us at MAPS 2025

Clinakos, Rare Disease, Integrated Patient Data, Medically Smart AI, MAPS 2025

We’re excited to announce our participation in the upcoming MAPS Annual Conference, taking place from March 23 – 26, 2025, in New Orleans. This event presents an excellent opportunity to connect with clients, partners, and collaborators. We look forward to engaging in insightful discussions on groundbreaking solutions powered by Clinakos Inc. Integrated Patient Data™ and […]

February 28 is Rare Disease Day

Clinakos, Integrated Patient Data, Medically Smart AI, Rare diseases

Rare diseases disproportionately affect children, with a staggering two-thirds of American rare disease patients being kids. This sobering statistic underscores the critical importance of early detection and intervention – a mission that drives us at Clinakos Inc. Meet Anthony, whose story, shared by National Organization for Rare Disorders, puts a face to this urgent need. […]

Rare Disease Month February

Clinakos, Integrated Patient Data, Medically Smart AI, Rare diseases

As Rare Disease Month approaches this February, we turn our attention to the extraordinary stories of individuals navigating life with conditions that often defy quick diagnosis and straightforward treatment. Their journeys are a testament to resilience and the urgent need for innovation. Recently, I came across with the story of Faye Louise, a 40-year-old from […]

Meet Us at SCOPE 2025

Clinakos, Integrated Patient Data, Medically Smart AI, Rare diseases, SCOPE

With over 4,500 attendees and 1,200 organizations from 30 countries coming together in clinical operations, innovation, and digital health, SCOPE 2025 promises to be a game-changer for the industry. The 2025 agenda has been expanded to provide deeper coverage of Patient-Centric Trial Design, Generative AI, Small Biopharma Strategies, and other key topics shaping the future […]

43rd Annual J.P Morgan Annual Healthcare Conference

Clinakos, Integrated Patient Data, Medically Smart AI, Rare diseases, JPM

The energy is incredible—packed meetings, buzzing lobbies, and excitement everywhere! Key themes taking center stage: ✨ Rare diseases and gene therapy, especially in immunology, are generating huge buzz. Optimism about the IPO window reopening is energizing conversations. Deal activity is anticipated to pick up momentum. Policy uncertainty with the new administration in Washington adds a […]

Accelerating Rare Disease Drug Development and Commercialization: Bridging Data Gaps with Integrated Patient Data & AI

Clinakos, Webinar, Integrated Patient Data, Medically Smart AI, Rare diseases

How Patient Data and AI are Revolutionizing Rare Disease Drug Development and Commercialization ✨The power of patient data and AI is reshaping how pharmaceutical companies approach drug development & commercialization—enabling unprecedented precision and speed. Imagine targeting the right patient population with pinpoint accuracy, crafting messages that resonate deeply with rare disease communities, and engaging stakeholders […]

Join Clinakos Inc. and Rare Patient Voice on February 4, 2025

Clinakos, Webinar, Integrated Patient Data, Medically Smart AI, Rare diseases

Join Clinakos Inc. and Rare Patient Voice on February 4, 2025, for an engaging webinar: “Accelerating Rare Disease Drug Development and Commercialization: Bridging Data Gaps with Integrated Patient Data™ & AI.” Did you know it often takes years for rare disease patients to receive an accurate diagnosis? With 1 in 10 people in the U.S. […]